Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220024/S005

LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device

Advanced Medical Solutions Limited · Decision date Jan 14, 2026

FDA DECISIONP220024/S005

What did the FDA approve?

FDA records P220024/S005 as a supplement to PMA P220024, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jan 14, 2026.

FDA approval order statement

approval of the revised protocol to enhance enrollment of the LIQUFIX Post-Approval Study (PAS). The changes are, namely, revising the enrollment milestone dates. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220024.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
General, Plastic Surgery
Decision date
Jan 14, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P220024/S005
Regulatory pathway
PMA supplement
Product code
PLJ
Decision code
APPR
Decision date
Jan 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tissue adhesive internal use.

Product code
PLJ
FDA device class
3

For the original device and its historical approval scope, see PMA P220024. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220024 · Original PMA

    LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device

  2. P220024/S005 received

    Application receipt date recorded by FDA.

  3. P220024/S005 · FDA decision

    Normal 180 Day Track No User Fee

  4. P220024/S007 · Related supplement

    LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device

Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220024

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Medical Solutions Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Western Wood Way, Langage Science Park, Plymouth, PL7 5BG

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records